Ocugen says it will pursue submission of a biologics license application for its ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Ocugen says it will pursue submission of a biologics license application for its COVID-19 vaccine candidate, COVAXIN in US "The Company will no longer pursue an Emergency Use Authorization for COVAXIN ," it says in a statement.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)